|
1
|
Keeley EC and Hillis LD: Primary PCI for
myocardial infarction with ST-segment elevation. N Engl J Med.
356:47–54. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martin-Rendon E, Brunskill SJ, Hyde CJ,
Stanworth SJ, Mathur A and Watt SM: Autologous bone marrow stem
cells to treat acute myocardial infarction: A systematic review.
Eur Heart J. 29:1807–1818. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Penn MS: Stem Cells and Myocardial
Regeneration. 1st. Humana Press; Totowa: pp. 2772007
|
|
4
|
Silva GV, Litovsky S, Assad JA, Sousa AL,
Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, et al:
Mesenchymal stem cells differentiate into an endothelial phenotype,
enhance vascular density, and improve heart function in a canine
chronic ischemia model. Circulation. 111:150–156. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rodrigo SF, van Ramshorst J, Hoogslag GE,
Boden H, Velders MA, Cannegieter SC, Roelofs H, Al Younis I,
Dibbets-Schneider P, Fibbe WE, et al: Intramyocardial injection of
autologous bone marrow-derived ex vivo expanded mesenchymal stem
cells in acute myocardial infarction patients is feasible and safe
up to 5 years of follow-up. J Cardiovasc Transl Res. 6:816–825.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fukuda K and Fujita J: Mesenchymal, but
not hematopoietic, stem cells can be mobilized and differentiate
into cardiomyocytes after myocardial infarction in mice. Kidney
Int. 68:1940–1943. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Castellani M, Colombo A, Giordano R,
Pusineri E, Canzi C, Longari V, Piccaluga E, Palatresi S,
Dellavedova L, Soligo D, et al: The role of PET with
13N-ammonia and 18F-FDG in the assessment of
myocardial perfusion and metabolism in patients with recent AMI and
intracoronary stem cell injection. J Nucl Med. 51:1908–1916. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saraste A, Kajander S, Han C, Nesterov SV
and Knuuti J: PET: Is myocardial flow quantification a clinical
reality? J Nucl Cardiol. 19:1044–1059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rahmim A and Zaidi H: PET versus SPECT:
Strengths, limitations and challenges. Nucl Med Commun. 29:193–207.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Slart RH, Bax JJ, van Veldhuisen DJ, van
der Wall EE, Dierckx RA and Jager PL: Imaging techniques in nuclear
cardiology for the assessment of myocardial viability. Int J
Cardiovasc Imaging. 22:63–80. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Slart RH, Bax JJ, van Veldhuisen DJ, van
der Wall EE, Irwan R, Sluiter WJ, Dierckx RA, de Boer J and Jager
PL: Prediction of functional recovery after revascularization in
patients with chronic ischaemic left ventricular dysfunction:
Head-to-head comparison between
99mTc-sestamibi/18F-FDG DISA SPECT and
13N-ammonia/18F-FDG PET. Eur J Nucl Med Mol
Imaging. 33:716–723. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Boer J, Slart RH, Blanksma PK,
Willemsen AT, Jager PL, Paans AM, Vaalburg W and Piers DA:
Comparison of
99mTc-sestamibi-18F-fluorodeoxyglucose dual
isotope simultaneous acquisition and rest-stress
99mTc-sestamibi single photon emission computed
tomography for the assessment of myocardial viability. Nucl Med
Commun. 24:251–257. 2003. View Article : Google Scholar
|
|
13
|
Hutton BF: The origins of SPECT and
SPECT/CT. Eur J Nucl Med Mol Imaging. 41 (Suppl 1):S3–S16. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Psaltis PJ, Zannettino AC, Worthley SG and
Gronthos S: Concise review: Mesenchymal stromal cells: Potential
for cardiovascular repair. Stem Cells. 26:2201–2210. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pittenger MF and Martin BJ: Mesenchymal
stem cells and their potential as cardiac therapeutics. Circ Res.
95:9–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Robey TE, Saiget MK, Reinecke H and Murry
CE: Systems approaches to preventing transplanted cell death in
cardiac repair. J Mol Cell Cardiol. 45:567–581. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song L, Yang YJ, Dong QT, Qian HY, Gao RL,
Qiao SB, Shen R, He ZX, Lu MJ, Zhao SH, et al: Atorvastatin enhance
efficacy of mesenchymal stem cells treatment for swine myocardial
infarction via activation of nitric oxide synthase. PLoS One.
8:e657022013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang YJ, Qian HY, Huang J, Li JJ, Gao RL,
Dou KF, Yang GS, Willerson JT and Geng YJ: Combined therapy with
simvastatin and bone marrow-derived mesenchymal stem cells
increases benefits in infarcted swine hearts. Arterioscler Thromb
Vasc Biol. 29:2076–2082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Soboleva EL, Gabbasov ZA, Agapov AA,
Akchurin RS, Saburova OS, Romanov YA and Smirnov VN: Circulating
bone marrow stem/progenitor cells in vascular atherogenesis and in
the noninvasive diagnosis of coronary stenosis. Exp Clin Cardiol.
10:184–188. 2005.PubMed/NCBI
|
